Secondary hypogonadism is a condition in which the testes (or ovaries) produce too little sex hormone, not because they are damaged, but because the brain fails to send them the right signals. The problem sits upstream, in the hypothalamus or pituitary gland, where the hormonal commands that drive testosterone or estrogen production originate. This makes it fundamentally different from primary hypogonadism, where the gonads themselves are the issue, and the distinction matters because it changes what caused the problem, how doctors diagnose it, and which treatments work.
How Secondary Hypogonadism Differs From Primary
The reproductive hormone system runs on a feedback loop between the brain and the gonads. The hypothalamus releases a signaling hormone called GnRH, which tells the pituitary gland to release two more hormones, LH and FSH. Those travel through the bloodstream to the testes, where they trigger testosterone production and sperm development. In primary hypogonadism, the testes are damaged or dysfunctional, so they cannot respond properly even though the brain is sending strong signals. The brain detects the low testosterone and ramps up LH and FSH even higher, trying to compensate. Blood work in primary hypogonadism shows low testosterone with high LH and FSH.
In secondary hypogonadism, the defect is in the hypothalamus or pituitary. The brain either does not produce enough GnRH or does not release enough LH and FSH. The testes are physically capable of making testosterone but never get the instruction to do so. On blood work, this shows up as low testosterone with low or inappropriately normal LH and FSH, a pattern that tells clinicians the brain, not the testes, is the weak link.1Endocrinology and Metabolism Clinics. Diagnosis and Evaluation of Hypogonadism That hormonal fingerprint is how doctors distinguish the two forms and decide where to look for the underlying cause.
Common Causes in Adults
Secondary hypogonadism has a wide range of triggers. Some are structural problems in the brain, but many are functional, meaning the signaling system is being suppressed by something reversible rather than physically broken. The most common causes in adult men fall into a few broad categories.
Obesity
Excess body fat is one of the most widespread drivers of secondary hypogonadism in men, and the condition grows more prevalent as obesity rates climb.2PubMed Central. Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity Fat tissue contains an enzyme called aromatase that converts testosterone into estrogen. In men carrying a lot of body fat, the increased estrogen, along with elevated levels of leptin, insulin, and inflammatory molecules, suppresses the hypothalamic neurons responsible for GnRH release.3PubMed Central. Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management The result is a vicious cycle: obesity drives testosterone down, and low testosterone promotes more fat accumulation, which suppresses testosterone further. The encouraging part is that this form of hypogonadism is often reversible. Significant weight loss, including through bariatric surgery, can normalize testosterone by reducing aromatase activity and the hormonal disruption that goes with it.4e-SPEN Journal. Hypogonadotropic hypogonadism among a population of obese men: Prevalence, risk factors and reversibility after weight loss induced by bariatric surgery
Opioids
Opioid medications, whether prescription painkillers or illicit drugs, are a well-documented cause. They act directly on the central nervous system to suppress GnRH release from the hypothalamus, which in turn reduces LH and FSH from the pituitary and drops testosterone production.5PubMed Central. Opioid induced hypogonadism The effect can begin within weeks of starting an opioid and tends to be dose-dependent. Men on long-term opioid therapy for chronic pain frequently develop symptoms like low libido and fatigue without realizing their medication is the cause. Recovery usually occurs after the opioid is discontinued, though this depends on the duration of use and the individual.
Anabolic Steroids
Anabolic-androgenic steroids flood the body with synthetic testosterone or similar hormones. The brain responds by shutting down its own GnRH and gonadotropin production, since it detects more than enough androgen already in circulation. Once the user stops, the brain’s signaling system needs time to restart. This withdrawal hypogonadism is common, and the recovery timeline is unpredictable. Gonadotropin levels generally normalize within three to six months, and testosterone production often returns over months to years, but the degree of recovery depends heavily on the user’s age and how long and how heavily they used.6PubMed Central. Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review
In some men, recovery stalls or remains incomplete. One study found that former steroid users who had been off the drugs for three to twenty-six months still had significantly smaller testes and lower testosterone levels than men who had never used steroids, with several showing testosterone below 200 ng/dL.7PubMed Central. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem Evidence now suggests that in some cases, particularly after prolonged heavy use, the suppression may be partially or completely irreversible.8PubMed. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men
Pituitary Tumors and Prolactinomas
A tumor in or near the pituitary gland can cause secondary hypogonadism in two ways. It can physically compress the surrounding pituitary tissue, destroying the cells that produce LH and FSH. Or, in the case of a prolactinoma (a tumor that secretes excess prolactin), the elevated prolactin itself suppresses the hypothalamic neurons that drive the reproductive axis.9PubMed. Hypogonadism in men with prolactinoma: Diagnosis, treatment, and management of persistent hypogonadism Prolactinomas are the most common type of pituitary tumor, and men with them often present first with sexual symptoms like erectile dysfunction before the tumor itself is discovered.
Genetic and Congenital Forms
Some people are born with a deficiency in GnRH production. Congenital hypogonadotropic hypogonadism, including the variant known as Kallmann syndrome, results from genetic mutations that affect the development or function of the GnRH-producing neurons in the hypothalamus. Kallmann syndrome is typically accompanied by a reduced or absent sense of smell, because the GnRH neurons and the olfactory nerves develop along the same pathway during fetal life. These conditions can also involve other features such as skeletal differences or hearing problems.10Endocrinol Metab (Seoul). Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future Congenital forms are rarer than the acquired causes listed above, but they matter in younger patients who fail to enter puberty at the expected age.
Recognizing the Symptoms
The symptoms of secondary hypogonadism overlap heavily with those of any testosterone deficiency. In adult men who developed the condition after puberty, the hallmark complaints are low sex drive, erectile dysfunction, fatigue, depressed mood, difficulty concentrating, and a general sense of feeling “off.” Over time, untreated hypogonadism leads to loss of muscle mass and strength, increased body fat, decreased bone density, and some regression of secondary sexual characteristics like reduced body hair.11PubMed Central. Diagnosis of hypogonadism: clinical assessments and laboratory tests
When the condition is present from birth or develops before puberty, the picture looks different. Adolescents may show delayed or absent pubertal development: no deepening of the voice, no growth of facial or body hair, underdeveloped genitalia, and sometimes a eunuchoid body habitus with long limbs relative to the trunk. These presentations lead to evaluation much earlier than the vague midlife symptoms that often prompt workup in adults.
Why Diagnosis Requires Careful Timing
Testosterone levels fluctuate throughout the day. In younger men, levels in the late afternoon can run 20 to 25 percent lower than early morning values. Even in older men, the difference is around 10 percent. This means a blood draw at the wrong time of day can produce a falsely low result. One study found that among men whose afternoon testosterone levels fell below 300 ng/dL, every single one tested normal when blood was drawn before noon.12PubMed Central. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men Guidelines accordingly recommend drawing blood in the morning, ideally between 7 and 10 a.m., after an overnight fast, and confirming a low result with a second test on a separate day.13Endocrinology and Metabolism Clinics. Diagnosis and Evaluation of Hypogonadism
Once low testosterone is confirmed, the LH and FSH levels tell the story. Low or normal LH and FSH alongside low testosterone points toward secondary hypogonadism. If testosterone is very low (below roughly 150 ng/dL), or if prolactin is elevated, or if there are symptoms like headaches or vision changes, an MRI of the pituitary region is typically ordered to rule out a tumor or other structural problem.13Endocrinology and Metabolism Clinics. Diagnosis and Evaluation of Hypogonadism
Treatment Options
Treatment depends on two things: the underlying cause and whether the patient wants to preserve fertility. These two considerations lead to very different approaches.
Testosterone Replacement Therapy
For men who do not plan to have children (or have completed their families), testosterone replacement therapy is the most straightforward treatment. It comes in several forms, including injections, topical gels, patches, and implantable pellets. TRT reliably improves mood, energy, sex drive, erectile function, lean body mass, muscle strength, and bone density.14PubMed Central. The benefits and risks of testosterone replacement therapy: a review In men with obesity-related secondary hypogonadism and metabolic conditions like type 2 diabetes, TRT has also shown favorable effects on body composition, increasing lean mass and reducing fat, though improvements in insulin resistance have been less consistent across studies.15PubMed Central. Metabolic Effects of Testosterone Replacement Therapy in Men with Functional Secondary Hypogonadism, Obesity and Type 2 Diabetes or Metabolic Syndrome: A Systematic Review
There is an important catch with TRT, and it is one that many men are not warned about clearly enough. Exogenous testosterone tells the brain that circulating hormone levels are high, causing the pituitary to further reduce LH and FSH secretion. This suppresses sperm production, sometimes to zero.16PubMed Central. Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility In other words, TRT can effectively act as male contraception. For a man with secondary hypogonadism who already has impaired signaling to the testes, adding exogenous testosterone makes the fertility situation worse, not better. This is arguably the single most important practical point in the entire topic: if you want children, do not start TRT without a clear conversation with your doctor about alternatives.
Clomiphene Citrate
Clomiphene is an oral medication originally developed for female infertility that has found an off-label role in male secondary hypogonadism. It works by blocking estrogen receptors in the hypothalamus, which tricks the brain into thinking estrogen (and by extension, testosterone) is lower than it actually is. The hypothalamus responds by increasing GnRH output, which raises LH and FSH, which stimulates the testes to produce more testosterone and sperm. In a study of 178 men with secondary hypogonadism and erectile dysfunction, clomiphene significantly increased both LH and free testosterone in all patients, and about three-quarters reported improvement in sexual function.17Nature. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? The appeal of clomiphene is that it works with the body’s own axis rather than replacing it, preserving sperm production in the process. It is commonly used by steroid users as part of so-called “post-cycle therapy” to restart their axis, though the evidence base for that specific application is thinner than many online forums suggest.8PubMed. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men
Gonadotropin Therapy for Fertility
When the goal is to father a child, the gold-standard treatment for secondary hypogonadism is gonadotropin injections, typically a combination of hCG (which mimics LH) and FSH. Because the testes in secondary hypogonadism are structurally intact, directly replacing the missing pituitary signals can kick-start both testosterone production and sperm development. The combination therapy usually runs for 12 to 24 months and promotes testicular growth in nearly all patients, spermatogenesis in about 80 percent, and pregnancy rates around 50 percent.18PubMed. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism Viable sperm can begin appearing in the ejaculate as early as three months into treatment, and some men with acquired secondary hypogonadism (for instance, after head trauma or surgery) have achieved natural conception without needing assisted reproduction.19PubMed. Is intracytoplasmic sperm injection essential for the treatment of hypogonadotrophic hypogonadism? This is one of the areas where the distinction between primary and secondary hypogonadism has the most practical significance: gonadotropin therapy works precisely because the testes are healthy and just need the right signal.
Monitoring Risks During Treatment
Testosterone therapy, whether through TRT or endogenous stimulation, requires monitoring. One of the more common side effects is erythrocytosis, an overproduction of red blood cells. This occurs in up to 40 percent of men on TRT, particularly older men and those using injectable formulations. Thicker blood raises the theoretical risk of clotting events and cardiovascular complications if left unchecked.20PubMed Central. Testosterone use causing erythrocytosis For this reason, periodic blood counts are part of standard follow-up for anyone on testosterone therapy. If red blood cell counts climb too high, dose adjustments or blood donation are the usual interventions.
Other monitoring includes checking prostate-specific antigen levels, liver function (for oral formulations), and repeating testosterone measurements to ensure levels stay within the target range. The monitoring burden is not trivial, but it is manageable, and skipping it is where problems tend to arise.
The Psychological Dimension
Low testosterone and depression have a bidirectional relationship that complicates both diagnosis and treatment. Men with hypogonadism frequently experience depressed mood, anxiety, insomnia, and memory difficulties. When these symptoms are mild, TRT often helps. But when depression is severe, testosterone replacement alone does not appear to resolve it.21PubMed Central. The association of hypogonadism with depression and its treatments The practical implication is that a man with secondary hypogonadism and significant depression likely needs treatment for both conditions simultaneously rather than hoping testosterone fixes everything.
What makes this trickier is that depression itself can contribute to functional hypogonadism. Chronic stress and mental health conditions can suppress the hypothalamic-pituitary axis through the same pathways that obesity and opioids do. A man who presents with low testosterone and depression may have one causing the other, or both may be feeding each other. Untangling this requires clinical judgment rather than a single blood test.
Secondary Hypogonadism in Women
Although the term “hypogonadism” is most commonly discussed in men, the same principle applies to women. The most recognized form of secondary hypogonadism in women is functional hypothalamic amenorrhea, where the hypothalamus reduces GnRH output in response to stress, excessive exercise, disordered eating, or some combination. This accounts for roughly a third of all cases of secondary amenorrhea (the loss of menstrual periods in someone who previously had them).22PubMed Central. Functional Hypothalamic Amenorrhea: Recognition and Management of a Challenging Diagnosis The hormone pattern mirrors what happens in men: low estrogen with low or inappropriately normal LH and FSH, because the brain is not sending the signal rather than the ovaries failing to respond.
The consequences extend well beyond missed periods. Chronic low estrogen leads to bone loss, cardiovascular risk, and impaired fertility. Treatment focuses on addressing the underlying trigger, whether that means reducing training volume, improving nutrition, managing psychological stress, or a combination.23The Journal of Clinical Endocrinology & Metabolism. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline Hormone replacement may be used in the interim to protect bone health, but addressing the root cause is what restores normal function.
When the Condition Appears Before Puberty
Secondary hypogonadism that is present from birth or develops during childhood raises a different set of concerns. The most immediate issue is the failure to enter puberty normally. Without adequate gonadotropin signaling, the testes do not enlarge, testosterone does not rise, and the cascade of pubertal changes (voice deepening, muscle development, growth of body and facial hair, genital maturation) does not occur on schedule. Differentiating true hypogonadotropic hypogonadism from constitutional delay of puberty, where a teenager is simply a late bloomer, remains one of the trickier diagnostic challenges in pediatric endocrinology.24PubMed Central. Etiology and treatment of hypogonadism in adolescents
For adolescents who do have confirmed secondary hypogonadism, treatment involves inducing puberty with carefully dosed hormones. Low-dose testosterone can be introduced gradually to mimic the natural pubertal rise, promoting physical development without prematurely closing the growth plates. If fertility is a long-term goal, gonadotropin therapy may eventually be used, since these patients’ testes, like those of adults with secondary hypogonadism, are typically capable of producing sperm when given the proper hormonal signals. The transition from pediatric to adult care is a critical window, and maintaining follow-up through it can prevent years of undertreated symptoms.
Addressing the Root Cause Versus Replacing the Hormone
One of the more underappreciated aspects of secondary hypogonadism is that in many cases, the smartest treatment is not hormone therapy at all but fixing whatever is suppressing the axis. For the man whose low testosterone stems from obesity, meaningful weight loss can restore normal levels without ongoing medication. For the woman whose periods stopped because of overtraining and undereating, dietary rehabilitation and reduced exercise volume can restart the cycle. For the patient on chronic opioids, a conversation about pain management alternatives or dose reduction may address the hypogonadism at its source.
This is where secondary hypogonadism differs most sharply from primary hypogonadism. When the testes or ovaries are permanently damaged, hormone replacement is lifelong. But when the brain is the bottleneck, and the bottleneck is being caused by something modifiable, the condition is often functional and reversible. The challenge is that reversing the cause, losing significant weight, tapering off opioids, recovering from an eating disorder, takes time and effort, and testosterone replacement offers faster symptom relief. The temptation to reach for the quick fix is understandable, but it can obscure the fact that the underlying condition is still there and still causing harm beyond just low hormone levels. Obesity-related hypogonadism, for instance, is tied to a wider set of metabolic problems including higher rates of type 2 diabetes, metabolic syndrome, and cardiovascular disease.2PubMed Central. Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity Normalizing testosterone with a gel does nothing for those risks if the weight stays the same.